Regulatory/Legislative News

Recently proposed legislation in Connecticut states that a provider may not use the data or information obtained from the administration of a test using a remote refractive device as the sole basis for issuing an initial prescription or renewing an initial prescription.

In the waning days of March, we all witnessed a fascinating event in American politics. Many of us clustered around the television to watch the vote on the American Health Care Act of 2017.

Alaska’s Senate Bill 36 and House Bill 103 seek to grant the state’s board of optometry control of Alaskan optometrists’ scope of practice.

NEW YORK – Retrospective case series research is a good place for optometrists who are interested in participating in clinical studies to get started, according to an experienced researcher.

In a letter to the newly confirmed U.S. Department of Health and Human Services secretary, Thomas Price, Prevent Blindness urged the secretary to prioritize adult and children’s vision health in consideration of the $145 billion spent on vision problems in the U.S. annually.

The Georgia Senate voted in favor of SB 153, which would allow doctors of optometry to perform certain types of injections in and around the eye, by a vote of 30-21.

AU-011, an investigational, first-in-class targeted therapy for ocular melanoma treatment, was granted fast track designation by the FDA, according to a press release from Aura Biosciences.

The first quarter of 2017 saw new developments at the FDA for many ophthalmic drug candidates or technological developments.

The Georgia House of Representatives approved legislation that would authorize optometrists in the state to perform limited injections to areas near the eye in a 121 to 36 vote on March 24.

An act has been introduced in California requiring that a student’s vision be appraised by a physician, optometrist or ophthalmologist.